General Information
Revision date
2022-07-22
Product name
INJECTION * ZINETAC INJECTION * RANITIDINE HYDROCHLORIDE, FORMULATED
Product Synonyms
ZANTAC INJECTION 25 MG/ML * ZANTAC INJECTION 25 MG/ML (NZ) * ZANTAC INJECTION
CAS No.
66357-59-3
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Skin corrosion/irritation Category 3 Sensitization, skin Category 1
Environmental hazards
Not classified.
Signal word
Warning
Hazard statements
Causes mild skin irritation. May cause an allergic skin reaction.
Prevention
Avoid breathing mist/vapours. Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves.
Response
Specific treatment (see instruction on this label). If skin irritation or rash occurs: Get medical advice/attention. Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
2.5 % of the mixture consists of component(s) of unknown acute dermal toxicity. 2.5 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 2.5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
